Stock Track | Genor Biopharma Plummets 7.40% Amid Broader Biotech Sector Decline in Hong Kong

Stock Track

Aug 27

Genor Biopharma (06998.HK) saw its stock price plummet by 7.40% during intraday trading on Wednesday, as the biotechnology sector in Hong Kong experienced a significant downturn. The sharp decline in Genor's shares reflects a broader trend affecting multiple companies in the biotech industry.

The sell-off in biotech stocks appears to be widespread, with several prominent companies in the sector facing substantial losses. This sector-wide decline suggests that investors may be reassessing their positions in biotechnology firms, possibly due to broader market factors or industry-specific concerns.

Other biotech companies also felt the impact of this downturn. Clover Biopharmaceuticals led the decline with a drop of over 14%, while Canbridge Pharmaceuticals fell nearly 8%. Additionally, Keymed Biosciences and JW (Cayman) Therapeutics experienced losses of 6% and 4% respectively. The simultaneous decline across multiple biotech stocks indicates a potential shift in market sentiment towards the sector as a whole.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1108285515"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1108285515\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1108285515?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-27 13:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1108285515","market":"nz","top_or_hot":-1,"title":"Stock Track | Genor Biopharma Plummets 7.40% Amid Broader Biotech Sector Decline in Hong Kong","media":"Stock Track","content":"<p>Genor Biopharma (06998.HK) saw its stock price plummet by 7.40% during intraday trading on Wednesday, as the biotechnology sector in Hong Kong experienced a significant downturn. The sharp decline in Genor's shares reflects a broader trend affecting multiple companies in the biotech industry.</p>\n\n<p>The sell-off in biotech stocks appears to be widespread, with several prominent companies in the sector facing substantial losses. This sector-wide decline suggests that investors may be reassessing their positions in biotechnology firms, possibly due to broader market factors or industry-specific concerns.</p>\n\n<p>Other biotech companies also felt the impact of this downturn. Clover Biopharmaceuticals led the decline with a drop of over 14%, while Canbridge Pharmaceuticals fell nearly 8%. Additionally, Keymed Biosciences and JW (Cayman) Therapeutics experienced losses of 6% and 4% respectively. The simultaneous decline across multiple biotech stocks indicates a potential shift in market sentiment towards the sector as a whole.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Genor Biopharma Plummets 7.40% Amid Broader Biotech Sector Decline in Hong Kong</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Genor Biopharma Plummets 7.40% Amid Broader Biotech Sector Decline in Hong Kong\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-08-27 13:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Genor Biopharma (06998.HK) saw its stock price plummet by 7.40% during intraday trading on Wednesday, as the biotechnology sector in Hong Kong experienced a significant downturn. The sharp decline in Genor's shares reflects a broader trend affecting multiple companies in the biotech industry.</p>\n\n<p>The sell-off in biotech stocks appears to be widespread, with several prominent companies in the sector facing substantial losses. This sector-wide decline suggests that investors may be reassessing their positions in biotechnology firms, possibly due to broader market factors or industry-specific concerns.</p>\n\n<p>Other biotech companies also felt the impact of this downturn. Clover Biopharmaceuticals led the decline with a drop of over 14%, while Canbridge Pharmaceuticals fell nearly 8%. Additionally, Keymed Biosciences and JW (Cayman) Therapeutics experienced losses of 6% and 4% respectively. The simultaneous decline across multiple biotech stocks indicates a potential shift in market sentiment towards the sector as a whole.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06998","symbol_name":"嘉和生物-B","start_time":0,"source_url":"","article_id":"1108285515","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1108285515","pubTimestamp":1756273136,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Genor Biopharma (06998.HK) saw its stock price plummet by 7.40% during intraday trading on Wednesday, as the biotechnology sector in Hong Kong experienced a significant downturn. The sharp decline in...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06998":"嘉和生物-B"},"translate_title":"个股追踪|嘉和生物制药暴跌7.40%香港生物科技板块普遍下跌","themeId":"1c8d330ce0386dff71942fca29a770ca","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06998":1},"content_text":"Genor Biopharma (06998.HK) saw its stock price plummet by 7.40% during intraday trading on Wednesday, as the biotechnology sector in Hong Kong experienced a significant downturn. The sharp decline in Genor's shares reflects a broader trend affecting multiple companies in the biotech industry.\nThe sell-off in biotech stocks appears to be widespread, with several prominent companies in the sector facing substantial losses. This sector-wide decline suggests that investors may be reassessing their positions in biotechnology firms, possibly due to broader market factors or industry-specific concerns.\nOther biotech companies also felt the impact of this downturn. Clover Biopharmaceuticals led the decline with a drop of over 14%, while Canbridge Pharmaceuticals fell nearly 8%. Additionally, Keymed Biosciences and JW (Cayman) Therapeutics experienced losses of 6% and 4% respectively. The simultaneous decline across multiple biotech stocks indicates a potential shift in market sentiment towards the sector as a whole.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}